These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30476149)

  • 1. Similarities and differences in the reproductive phenotypes of women with congenital hypogonadotrophic hypogonadism caused by GNRHR mutations and women with polycystic ovary syndrome.
    Maione L; Fèvre A; Nettore IC; Manilall A; Francou B; Trabado S; Bouligand J; Guiochon-Mantel A; Delemer B; Flanagan CA; Macchia PE; Millar RP; Young J
    Hum Reprod; 2019 Jan; 34(1):137-147. PubMed ID: 30476149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of KISS1 Receptor mutations in a series of 603 patients with normosmic congenital hypogonadotrophic hypogonadism and characterization of novel mutations: a single-centre study.
    Francou B; Paul C; Amazit L; Cartes A; Bouvattier C; Albarel F; Maiter D; Chanson P; Trabado S; Brailly-Tabard S; Brue T; Guiochon-Mantel A; Young J; Bouligand J
    Hum Reprod; 2016 Jun; 31(6):1363-74. PubMed ID: 27094476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH stimulation testing and serum inhibin B in males: insufficient specificity for discriminating between congenital hypogonadotropic hypogonadism from constitutional delay of growth and puberty.
    Mosbah H; Bouvattier C; Maione L; Trabado S; De Filippo G; Cartes A; Donzeau A; Chanson P; Brailly-Tabard S; Dwyer AA; Coutant R; Young J
    Hum Reprod; 2020 Oct; 35(10):2312-2322. PubMed ID: 32862222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of ncHH: from a peculiar inheritance of a novel GNRHR mutation to a comprehensive review of the literature.
    Cioppi F; Riera-Escamilla A; Manilall A; Guarducci E; Todisco T; Corona G; Colombo F; Bonomi M; Flanagan CA; Krausz C
    Andrology; 2019 Jan; 7(1):88-101. PubMed ID: 30575316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
    Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
    Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome.
    Liu DM; Torchen LC; Sung Y; Paparodis R; Legro RS; Grebe SK; Singh RJ; Taylor RL; Dunaif A
    Hum Reprod; 2014 Dec; 29(12):2764-72. PubMed ID: 25336708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular defects of the GnRH-receptor gene in Chinese patients with idiopathic hypogonadotropic hypogonadism and the severity of hypogonadism.
    Fathi AK; Hu S; Fu X; Huang S; Liang Y; Ning Q; Luo X
    J Pediatr Endocrinol Metab; 2012; 25(7-8):659-68. PubMed ID: 23155690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
    Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole Exome Sequencing Revealed a Novel Nonsense Variant in the GNRHR Gene Causing Normosmic Hypogonadotropic Hypogonadism in a Pakistani Family.
    Hussain HMJ; Murtaza G; Jiang X; Khan R; Khan M; Kakakhel MBS; Khan T; Wahab F; Zhang H; Zhang Y; Khan MB; Ahmed P; Ma H; Xu Z
    Horm Res Paediatr; 2019; 91(1):9-16. PubMed ID: 30947225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys.
    Abbott DH; Rayome BH; Dumesic DA; Lewis KC; Edwards AK; Wallen K; Wilson ME; Appt SE; Levine JE
    Hum Reprod; 2017 Apr; 32(4):923-936. PubMed ID: 28333238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study.
    Pinola P; Morin-Papunen LC; Bloigu A; Puukka K; Ruokonen A; Järvelin MR; Franks S; Tapanainen JS; Lashen H
    Hum Reprod; 2014 Oct; 29(10):2317-25. PubMed ID: 25056088
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Gonçalves CI; Aragüés JM; Bastos M; Barros L; Vicente N; Carvalho D; Lemos MC
    Endocr Connect; 2017 Aug; 6(6):360-366. PubMed ID: 28611058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term changes in hormonal profiles after laparoscopic ovarian laser evaporation compared with diagnostic laparoscopy for PCOS.
    Hendriks ML; König T; Korsen T; Melgers I; Dekker J; Mijatovic V; Schats R; Hompes PG; Homburg R; Kaaijk EM; Twisk JW; Lambalk CB
    Hum Reprod; 2014 Nov; 29(11):2544-52. PubMed ID: 25267790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
    Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
    Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the distribution of serum anti-müllerian hormone levels among infertile Asian women: a multi-nation, multi-centre, and multi-ethnicity prospective cohort study.
    Tzeng CR; Huang Z; Asada Y; Zhang C; Ho MT; Li RHW; Kim JH; Govindarajan M; Vuyavanich T; Sini I; Wong PS; Singh S; Lin WY; Ho NT
    Hum Reprod; 2023 Jul; 38(7):1368-1378. PubMed ID: 37105234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations.
    Francou B; Bouligand J; Voican A; Amazit L; Trabado S; Fagart J; Meduri G; Brailly-Tabard S; Chanson P; Lecomte P; Guiochon-Mantel A; Young J
    PLoS One; 2011; 6(10):e25614. PubMed ID: 22031817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
    J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.